Inhibitory effects of nicotinamide on recombinant human interferon-gamma-induced intercellular adhesion molecule-1 (ICAM-1) and HLA-DR antigen expression on cultured human endothelial cells

This publication has 19 references indexed in Scilit:

• Prevention or delay of Type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide
  Diabetologia, 1991
• Cytokines as communication signals between leukocytes and endothelial cells
  Immunology Today, 1989
• Expression of an intercellular adhesion molecule, ICAM-1, by human thyroid cells
  Journal of Endocrinology, 1989
• ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells
  Nature, 1988
• Human T-Cell Clones from Autoimmune Thyroid Glands: Specific Recognition of Autologous Thyroid Cells
  Science, 1985
• ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITY
  The Lancet, 1983
• Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.
  The Journal of Experimental Medicine, 1983
• Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) mice
  Diabetes, 1982
• Endothelial cell presentation of antigen to human T cells
  Human Immunology, 1981
• Poly(ADP-ribose) levels in carcinogen-treated cells
  Nature, 1979